| |
|
|
|
Evofem Biosciences Inc  
|
|
3.455 0.165 (0.05%) |
06-05 11:04 |
|
Open: |
3.43 |
Pre close: |
3.29 |
Target:
|
6.39
|
|
High: |
3.48 |
Low: |
3.37 |
Resistance:
|
5.47
6.87
|
|
Volume: |
2,846,197 |
Market Cap: |
172M |
Support:
|
3.20
2.66
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.97
 |
MACD |
MACD(12,26):
|
-0.33 |
|
MA(20): |
4.89 |
Signal(12,26,9): |
-0.10 |
|
MA(100): |
5.17 |
Stochastic Oscillator |
%K(14,3):
|
3.01 |
|
MA(250): |
5.37 |
%D(3): |
9.69 |
|
Average Volume(K) |
3-Month: |
147421
|
52-Week |
High:
|
7.50 |
|
10-Days: |
738486 |
Low: |
3.20 |
|
RSI |
RSI(14):
|
30.34  |
Change(%): |
-46.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.780 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
49.70 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
-386.4 |
Shares Float (M) |
34.69 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
30.97 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
75.27 |
|
Forward EPS |
-1.990 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
2140 |
|
Book Value (p.s.) |
0.020 |
EBITDA (p.s.) |
-1.169 |
P/E |
-1.91 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
169.95 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-62.30 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-41.36 |
P/CF |
-2.71 |
|
|
|
|
|
|
